The antifibrinolytic function of factor XIII is exclusively expressed through α2-antiplasmin cross-linking
Open Access
- 9 June 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (23), 6371-6374
- https://doi.org/10.1182/blood-2011-02-333203
Abstract
Factor XIII (FXIII) generates fibrin-fibrin and fibrin-inhibitor cross-links. Our flow model, which is sensitive to cross-linking, was used to assess the effects of FXIII and the fibrinolytic inhibitor, α2-antiplasmin (α2AP) on fibrinolysis. Plasma model thrombi formed from FXIII or α2AP depleted plasma lysed at strikingly similar rates, 9-fold faster than pooled normal plasma (PNP). In contrast, no change was observed on depletion of PAI-1 or thrombin activatable fibrinolysis inhibitor (TAFI). Inhibition of FXIII did not further enhance lysis of α2AP depleted thrombi. Addition of PNP to FXIII or α2AP depleted plasmas normalized lysis. Lysis rate was strongly inversely correlated with total cross-linked α2AP in plasma thrombi. Reconstitution of FXIII into depleted plasma stabilized plasma thrombi and normalized γ-dimers and α-polymers formation. However, the presence of a neutralizing antibody to α2AP abolished this stabilization. Our data show that the antifibrinolytic function of FXIII is independent of fibrin-fibrin cross-linking and is expressed exclusively through α2AP.Keywords
This publication has 20 references indexed in Scilit:
- Model thrombi formed under flow reveal the role of factor XIII‐mediated cross‐linking in resistance to fibrinolysisJournal of Thrombosis and Haemostasis, 2010
- TAFIa, PAI‐1 and α2‐antiplasmin: complementary roles in regulating lysis of thrombi and plasma clotsJournal of Thrombosis and Haemostasis, 2007
- A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestionBlood, 2004
- Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriagesBlood, 2003
- FACTOR XIII DEFICIENCYBritish Journal of Haematology, 1999
- Transglutaminase Inhibition by 2-[(2-Oxopropyl)thio]imidazolium Derivatives: Mechanism of Factor XIIIa InactivationBiochemistry, 1994
- Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.JCI Insight, 1983
- Significance of Cross-Linking of α2-Plasmin Inhibitor to Fibrin in Inhibition of Fibrinolysis and in HemostasisJCI Insight, 1982
- Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.JCI Insight, 1980
- γ-γ Cross-linking sites in human and bovine fibrinBiochemistry, 1971